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intrarenal ream and angiotensins in glycerol-induced acute re-
nal failure. Intrarenal renin and angiotensins were measured in
rats with glycerol-induced acute renal failure. Dehydrated, non-
dehydrated and chronically saline-loaded animals were studied
before and 1, 6, 17, 24, and 48 hours after glycerol injection.
Dehydrated and nondehydrated animals had a significant in-
crease in intrarenal renin 17 hours following glycerol injection, a
time when renal failure was already established. Renal renin con-
centration after 3 weeks of saline-loading was significantly de-
pressed. There was no change in intrarenal renin after the admin-
istration of glycerol in salt-loaded animals. Renal angiotensin 1
was unchanged early in acute renal failure in those animals which
developed the syndrome (dehydrated and nondehydrated).
There was, however, a marked increase 6 to 48 hours after glyc-
erol administration. No changes were observed in the salt-loaded
animals given glycerol, There was no increase in renal angioten-
sin II levels in alt groups studied except for a small but significant
increase 17 to 48 hours after glycerol administration in dehy-
drated animals; the magnitude of this elevation was small com-
pared to the change in angiotensin 1. Since changes in renal func-
tion preceded any change in the concentration of intrarenat renin
and angiotensins, it is unlikely that angiotensins participate in the
generation of this type of experimental acute renal failure. It can-
not be ruled out, however, that at a later stage of acute renal
failure these peptides play some role in the maintenance of the
syndrome.
Rénine et angiotensines intra-rénales dans l'insuftlsance rénale
aiguë par Ic glycerol. La refine et les angiotensines intra-rénales
ont été mesurées chez des rats atteints d'insuffisance rénale in-
duite par Ic glycerol. Des animaux deshydrates, non déshy-
dratés et charges en sd ont ttC étudiCs avant t 1, 6, 17, 24, 48
heures après l'injection de glycerol. Les animaux deshydrates et
non dCshydrates ont une augmentation significatIve de Ia rénine
rCnale 17 heures après l'injection de glycerol, alors que
l'insuffisance rCnale est déjà installCe. La concentration renale
de réninc est significativement abaissée aprs 3 semaines de
charge en set. L'administration de glycerol a ces animaux ne
muddle pas Ia rénine intra-rénale. L'angiotensine I rCnale n'est
pas modifiée a Ia phase précoce de l'insufilsance rénale chex les
animaux qui développent cc syndrome (deshydrates et non
déshydratés). Ii y a, cependant, une augmentation importante 6
a 48 heures apres l'administration de glycerol. II n'y a pas de
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modification chez les animaux charges en sd. 11 n'a pas été ob-
serve d'augmentation des concentrations d'angiotensine II ye-
nale dans les groupes Ctudiés fi l'exception d'une augmentation
minime mais significative 17 a 48 heures aprés Ic glycerol chez
les animaux deshydrates, L'amplitude de cette élévation est
minime comparee a Ia modification de l'angiotensine I. Du fait
que les modifications de Ia fonction rénale prêcèdent celles de Ia
rénine et des angiotensines intra-rénales il est peu probable que
les angiotensines patticipent a Ia génération de ce type
d'insuffisance rénale aigué expéritnentale. On ne peut pas cx-
clure, cependant, qu'a an stade ultérieur de l'insufiisance rCnale
aiguC ces peptides puissent jouer un role dans Ic niaintien du
syndrome.
A role for renin in the pathogenesis of acute renal
failure was originally proposed by Goormaghtigh
[1]. He suggested that overactivity of the renin-an-
giotensin system might lead to afferent arteriolar
constriction which in turn could predispose to the
development of acute renal failure. This hypothesis
has been supported by the observation of high lev-
els of renin [2—61 and angiotensin H [7, 81 in the pe-
ripheral blood of subjects with acute renal failure.
Furthermore, there is decreased susceptibility to
experimentally induced acute renal failure in low re-
nm states [9—121 as opposed to increased suscepti-
bility in high renin states [13, 14].
Components necessary for the formation of an-
giotensin H are present in the kidney [15—17]. Thus,
the local generation of high concentrations of angio-
tensin II in the vicinity of the juxtaglomerular cells
may elicit afferent arteriolar constriction, reducing
renal blood flow and glomerular filtration rate
(GFR). Angiotensin II may also have a direct effect
on the glomerular capillaries [181. producing both
capillary constriction and a decrease in glomerular
permeability [191, Therefore, intrarenal angiotensin
II could causally participate in the functional mani-
festations of acute renal failure; levels of intrarenal
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angiotensin II would not necessarily parallel those
occurring in the peripheral circulation.
We evaluated the participation of the intrarenal
renin-angiotensin system in the pathogenesis of
acute renal failure by measuring intrarenal renin
and angiotensin at different times in the course of
mild and severe forms of glycerol-induced acute
renal failure in rats. The possible correlation of
these levels with the observed renal functional
changes was examined. Whether protection from
renal failure afforded by chronic saline-loading par-
allels a depression of intrarenal renin and angioten-
sin II was studied in an identical fashion.
According to the above hypothesis [1], elevation
of the intrarenal concentration of angiotensin II
should coincide with a fall in GFR (or a rise in blood
urea nitrogen) following the initiation of acute renal
failure.
Methods
Experimental model. Studies were performed on
female Sprague-Dawley rats weighing between 200
and 250 g. The experimental animals were divided
into three groups. Series-I animals were maintained
on a routine diet of Purina laboratory chow and tap
water and are referred to as nondehydrated (N = 12
rats per time period). Water was withheld for 24
hours prior to induction of renal failure in the series-
2 animals, referred to as dehydrated (N = 8 rats per
time period). The drinking fluid of the series-3 ani-
mals was replaced with 0.9% sodium chloride for 3
weeks prior to the induction of experimental acute
renal failure. These animals are referred to as saline-
loaded (N = 8 rats per time period).
Myohemoglobinuric acute renal failure was in-
duced by the i.m. injection of 10 ml/kg of body
weight of 50% glycerol in tap water. While the con-
trol and experimental animals were under sodium
pentobarbital anesthesia (30 mg/kg, i.p.), both kid-
neys were removed from them at 1, 6, 17, 24, and 48
hours after glycerol injection; these kidneys were
frozen immediately at —70° C. Blood samples were
also obtained from the abdominal aorta for the mea-
surement of blood urea nitrogen (BUN) concentra-
tion (Beckman urease method). The right kidney
was used for determination of renin content, and
the contralateral kidney, for angiotensin I (Al) and
II (All).
Intra renal renin extraction and determination.
This method is a modification of the Haas technique
[20] and has been used for the quantitation of renin
content in tissues [21]. Each whole kidney was
weighed and then frozen and thawed four times pri-
or to homogenization in a Potter-Elvehjem tissue
grinder with 1 ml of distilled water per gram of wet
kidney weight, The homogenate was centrifuged at
4° C for 30 mm at x2,500g, and the supernatant
saved. The precipitate was resuspended with 1 ml
of distilled water on a vortex mixer, followed by
centrifugation for 30 mm at 4° C and x2,500g. The
supernatants were combined and adjusted to a pH
of 2.6 with 1.0 N sulfuric acid. To this mixture, 95%
ethyl alcohol was added to a final concentration of
10%. The mixture was allowed to stand at 4° C for 1
hour, followed by centrifugation for 30 mm at
X2,500g. The supernatant was decanted and adjust-
ed to a pH of 4.5 with 1.0 N sodium hydroxide and
dialyzed against distilled water for 17 hours at 4° C.
The dialysate was adjusted to a pH of 4.5 with 1.0 N
sodium hydroxide, and ammonium sulfate was
added to a final concentration of 2.4 M. After stand-
ing at 4° C for 30 mm, the mixture was centrifuged
for 30 mm at x2,500g. The precipitate was sus-
pended in 1 ml of distilled water and dialyzed
against water at 4° C for 17 hours. The dialysate
was then centrifuged for 30 mm at X 2,500g. and the
supematant was frozen at —70° C until assayed. A
portion of the supernatant was incubated at 37° C at
a pH of 6.2 for 30 mm with an excess of rat renin
substrate obtained as described below. Ten micro-
liters of 0.34 M 8-hydroxyquinoline sulfate and lOp1
of 0.906 M dimercaprol were added as converting
enzyme and angiotensinase inhibitors, respectively.
The total volume of the incubate was 1 ml. The in-
cubation was terminated by placing the mixture in a
boiling water bath for 10 mm followed by centrifu-
gation at 4° C for 20 mm at x2,500g. The angioten-
sin I generated was measured by radioimmunoassay
as outlined below. Renin concentration was ex-
pressed as micrograms of Al per milliliter per hour
per kidney.
Renin substrate. Blood samples for the prepara-
tion of renin substrate (RS) were obtained from
anesthetized rats 24 hours after bilateral nephrecto-
my and were placed in cold tubes (4° C) containing
EDTA [22]. Sufficient plasma was pooled and fur-
ther processed by dialysis against disodium-EDTA
(5.9 mM) for 24 hours at 4° C, followed by dialysis
against distilled water for another 24 hours. The
dialysate was centrifuged for 30 mm at x 1,600g. fol-
lowed by a pH adjustment to 6.2 by dialysis against
0.1 M sodium acetate (pH, 6.2). The substrate prep-
aration was kept frozen at —70° C until used. The
concentration of this substrate preparation was
942.0 9.7 ng of angiotensin I equivalents per mil-
liliter of substrate (N = 4 determinations) when in-
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cubated with excess renin. The preparation of renin
used for substrate measurement from normal rat
kidney was as outlined above.
The substrate preparation was tested for renin
and angiotensinase activities. Incubation of the sub-
strate preparation for 30 mm at 37° C without added
renin did not generate AT. Angiotensinase activity
was determined by adding Alto the incubation mix-
ture without added renin. It was incubated for 30
mm at 37° C. Incubation was terminated by placing
the mixture in a boiling water bath, followed by cen-
trifugation and AT measurement by radioimmunoas-
say, No angiotensinase activity was detected.
Intrarenal angiotensin determination. Angioten-
sin I and II were measured by a modification of
techniques previously used to extract angiotensins
from blood and tissue [23, 24]. Each whole kidney
was weighed and homogenized in a Potter-Elveh-
jem tissue grinder at 4° C with 20 ml of cold 80%
ethyl alcohol. The suspension was allowed to stand
for 17 hours at 4° C, followed by centrifugation at
0° C for 10 mm at xlO,000g. The supernatant was
saved and the precipitate washed two times with 5-
ml volumes of cold 80% ethyl alcohol. The super-
natants were pooled and applied to a 0.4 x 4-cm
column of Dowex 50W-X-4 ion exchange resin (hy-
drogen ion form) equilibrated with 80% ethyl alco-
hol. The sample was washed onto the column with a
5-ml volume of 80% ethanol, followed by distilled
water until no further protein emerged. Al and All
were eluted with 0.1 N sodium hydroxide. Total vol-
ume of the eluate was 4.0 ml. After neutralization to
a pH of 7.0 with 1 N hydrochloric acid this angioten-
sin-containing mixture was concentrated to I ml at
50° C under a stream of air. Al and All were mea-
sured by radloimmunoassay in aliquots of the con-
centrated solution. Each sample was assayed at two
different dilutions to discount nonspecific inter-
ference. All values given for Al and All immuno-
reactive material are not corrected for recovery.
The concentration of Al and All is expressed as
nanograms per kidney.
Angiotensin I assay. Al was measured by the
method of Haber et a! [25]. Antibody, radiolabeled
Al, and charcoal were obtained from Squibb
(Princeton, NJ). The incubation mixture consisted
of unknown sample added to 0.1 M Tris buffer (pH,
9.0) containing 1 mg/mI bovine serum albumin. Fif-
ty microliters of antiserum and 50 l of labeled Al
(approximately 10,000 counts/mm) were added to
the incubation mixture. The final volume of the mix-
ture was I ml and was incubated for 20 hours at
4°C.
The separation of free from bound Al was accom-
plished with 1 ml of dextran-coated charcoal sus-
pension. Tubes were centrifuged at 2,500 rpm at
4° C and the supernatant decanted. The supernatant
and charcoal were counted in a gamma scintillation
counter.
Angiolensin II assay. The radioimmunoassay
used was the method of Bailie, Rector, and Seldin
[26]. Antisera were produced in rabbits after immu-
nization with 1-aspartyl, 5-isoleucine All (Beck-
man, Calif.) conjugated to rabbit serum albumin
with carbodiimide [27]. Radiolabeled All was ob-
tained from New England Nuclear (Boston, Mass.).
The incubation mixture consisted of the unknown
sample added to 0.1 M tris buffer (pH, 8.6) contain-
ing 1 mglml bovine serum albumin and 2 mg/mI neo-
myocin sulphate. Fifty microliters of antiserum at a
dilution of 1: 4,000 and 50 pA of labeled All (ap-
proximately 10,000 counts/mm) were added to the
incubation mixture. The final volume of the mixture
was 0.5 ml, and this was incubated for 20 hours at
4°C.
The separation of free from bound angiotensin II
was accomplished with 100 pA of dextran-coated
charcoal suspension [28]. Tubes were centrifuged at
2,500 revolutions/mm at 4° C and the supernatant
decanted. Supernatant and charcoal were counted
in a gamma scintillation counter.
Nonspecific binding in the radioimmunoassay.
Nonspecific binding of a tissue extract was tested in
the Al and All immunoassay. To determine this po-
tential binding, an aliquot of kidney extract was
added to the assay incubation mixture without the
respective antibody. This would permit the extract
to compete with added charcoal to bind radioactive
angiotensin. Deletion of antibody and extract from
the incubation mixture would then allow added
charcoal to bind virtually all the radioactive angio-
tensin. Therefore, in the absence of nonspecific
binding, radioactivity in the supernatant would be
expected to be minimal. When a sample of kidney
extract is added to the incubation mixture without
antibody and exposed to charcoal, the radioactivity
remaining in the supernatant should reflect the
amount bound by the added sample. Therefore, the
radioactivity located in the supernatant under these
conditions would represent nonspecific binding by
the tissue extract.
Measurement of recoveries: (a) 1251-labled Al and
All. The recovery of radioactive tracer was as-
sessed twice during the extraction procedure for
angioten sins. Approximately 10,000 counts/mm of
125A1 or '25A11 were added to a kidney homogenate,
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and recovery from tissue was measured before ap-
plication on the Dowex column. Total recovery was
measured after the column adsorption and concen-
tration steps by gamma scintillation counting.
(b) Unlabeled Al, All, and Aill. Recovery was
determined by adding known amounts of A!, All,
and All! standard (10, 20, or 30 ng each) to an ali-
quot of a pooled kidney homogenate. This homoge-
nate contained approximately the same amount of
kidney tissue per aliquot as used during the extrac-
tion of the experimental kidney. To one aliquot no
angiotensin was added. This sample served as a
blank for endogenous angiotensin and was proc-
essed in parallel with those which contained added
angiotensin. After extraction, Dowex adsorption,
and concentration of the samples, Al, Al!, and AIll
were measured by radioimmunoassay.
All data were analyzed using Student's t test for
independent means and analysis of variance. Data
to determine variability of the renin extraction were
analyzed using the paired t test. Values are reported
as mean SEM.
Results
Renin extraction. The variability of both the ex-
traction and renin assay procedure was assessed by
comparing intrarenal renin content in kidneys from
the same animal. This included 40 pairs of kidneys
from normal animals and animals with acute renal
failure. The mean renin content of left kidneys was
98.6 8.0 jsg of Al/mi/hr/kidney, and that of the
right kidneys was 93;6 6.6 jsg of Al/mi/hr/kidney,
values which do not differ significantly (P > 0.1).
Since the renin extraction and angiotensin extrac-
tion differ methodologically, it was impractical to
study both renin and angiotensin in the same kid-
ney. Therefore, when it was established that kidney
pairs from the same animal had similar renin con-
tents, it became reasonable to correlate renin con-
tent in one kidney with angiotensin concentration in
the other kidney.
Radioimmunoassay of Al and All: (a) Non-
specific interference. Figs. 1 and 2 depict typical
standard curves for A! and A!!, respectively. They
demonstrate that natural angiotensin extracted from
tissue and standard angiotensin peptide added to
the final kidney extract react with their antibodies
as do the aqueous angiotensin standards. Further-
more, serial dilution of natural angiotensin in the
extracted tissue or the standard added to a kidney
extract resulted in an expected decrease in anti-
body-binding, with the values falling at the predict-
ed intervals on the standard curve. These data in-
Al, pg
Fig. 1. The effect of serial dilution of endogenous angiotensin I in
two kidney extracts (0, A) and angiotensin I added to a kidney
extract (0). The diluted samples fail at the expected intervals on
the standard curve (•—•).
dicate that the substance in the kidney extract de-
tected by the assay behaves antigenically in a
manner indistinguishable from standard peptide. It
also demonstrates the absence of nonspecific inter-
ference, that is, if inhibitors were to interfere in the
antibody-antigen reaction, the competitive effect
would not be expected to dilute out in a regular
fashion.
(b) Nonspecific binding. Addition of the kidney
extract without antibody in the Al assay resulted in
1.22 0.1% radioactivity in the supernatant
(N = 4), whereas the sole addition of charcoal yield-
ed 1.05 0.02% supernatant activity, values which
are not significantly different. Addition of the kid-
ney extract without antibody in the All assay re-
sulted in 2.46 0.4% radioactivity in the super-
natant (N = 7), whereas the sole addition of char-
coal yielded 1.69 0.2% supernatant radioactivity,
values not significantly different. Thus, addition of
tissue extract to the Al and All immunoassay by
itself does not alter measurement of the natural pep-
tide.
(c) Antibody specificity. Specificity of both an-
C
=0
m
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giotensin antibodies was evaluated by comparing
the degree of cross-reactivity of standard AT, All,
and Au. A known amount of Al, All, or Aill pep-
tide was added to the normal Al and All assay in-
cubation mixture. The assays were then performed
as described above. Values of cross-reactivity were
expressed as the percent of added peptide bound by
the tested antibody. The cross-reactivity was tested
up to the highest peptide concentration assayable.
Under these experimental conditions, the A! anti-
body cross-reacted 0.7% with All and 4.18% with
AIlI. The All antibody on the other hand cross-re-
acted 0.6% with Al and 93.8% with Alli.
Recoveries: (a) Radiolabeled Al and All. There
was no difference between recovery of radiolabeled
Al (76.9 1.5%, N = 4 kidneys) and All (78.5
1.2%, N = 5 kidneys) from normal kidneys and no
difference between the recovery of radiolabeled All
from normal kidneys or those from acute renal fail-
ure animals (78.3 1.3%, N = 4 kidneys).
(b) Unlabeled Al, All and AIlI. Mean recovery
from normal kidney homogenates for Al, All, and
All! was 88.8 3.8%, N = 7 kidneys; 91.2 3.5%,
N = 7 kidneys; and 86.4 5.3%, N = 10 kidneys,
respectively.
The peptide nature of the immunoreactive materi-
al extracted from kidney tissue was confirmed by
the demonstration that this material is dialyzable
and stable to boiling. Dialysis at 4° C against water
for 6 hours caused a 71% decrease of angiotensin
concentration compared to a nondialyzed control.
Boiling of the kidney extracts for 10 mm resulted in
only a 13.5% loss of angiotensin immunoreactivity.
Intrarenal renin content (Table 1). Nondehy-
drated animals developed a mild form of acute
renal failure. BUN was significantly increased from
1 through 48 hours. Twenty-four hours after glycer-
ol injection, the mean BUN was 75.7 9.8 mg/dl.
Intrarenal renin content was significantly elevated
above that of control at 1, 17, 24, and 48 hours after
glycerol.
Dehydrated animals developed severe acute renal
failure. The BUN was significantly elevated from 1
through 48 hours, with a maximum of 255.4 15.7
mg/dl at 48 hours. Intrarenal renin did not change
from control values during the first 6 hours. At 17,
24, and 48 hours the intrarenal renin content was
significantly increased above control.
Salt-loaded animals were relatively protected
from acute renal failure (Table 1). The mean BUN
at 24 hours after glycerol injection was 25.3 3.4
mg/dl. Intrarenal renin content was significantly ele-
vated at 24 hours after glycerol.
Intrarenal renin content from control and experi-
mental kidneys of nondehydrated animals was not
different from that of dehydrated animals at all
times measured; however, the renin content of the
nondehydrated and dehydrated groups was signifi-
cantly different from that of salt-loaded animals
(P < 0.05) at all times except at 1 hour (dehydrated
vs. saline-loaded) and at 6 hours (nondehydrated
vs. saline-loaded) after glycerol injection.
Intrarenal Al and All (Table 2). There was a sig-
nificant (P <0.05) increase in Al content in kidneys
from nondehydrated animals 6 to 48 hours after
glycerol, with a peak value of 16.05 3.10 ng/kidney
at 17 hours. All did not change significantly. Kid-
neys from dehydrated animals also had a significant
(P <0.05) increase in Al content from 6 to 48 hours,
the highest value being 44.06 15.60 ng/kidney at
24 hours. All content was significantly decreased in
6 hours (P <0.001) and elevated at 17 and 48 hours
(P < 0.01). Al and All contents of kidneys from
salt-loaded animals were unchanged throughout the
course of acute renal failure.
Al content of kidneys from saline-loaded animals
300
All, pg
Fig. 2. The effect of serial dilution of endogenous angiozensin II
in two kidney extracts (0, and angiotensin II added to a kid-
ney extract (0). The diluted samples fall at the expected inter-
vals on the standard curve (•—•).
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Table 1. Intrarenal renin (IR) and BUN in the course of glycerol-induced acute renal failure in nondehydrated, dehydrated, and saline-
loaded ratsa
Nondehydrated Dehydrated Saline-loaded
(N 12 rats/time period; total = 72) (N 8 rats/time period; total = 48) (N = 8 rats/tune period; total 40)
Time IR BUN IR BUN IR BUN
hr j.g Al/mi/hr/kidney mg/dl j.g Al/mi/hr/kidney mg/di Al/mi/hr/kidney mg/di
0 94.2 11.4 20.5 0.5 123.5 14.5 23.4 1.5 66.6 5.0 18.1 0.5
145.6 l3.9c 25.1 l,3C 115.1 23.0 30.9 2.Sb 76.7 5.4 23.4 l.2C
6 100.5 16.1 41,1 1,4d 115.9 16.9 65.1 1,7d 72.5 5.9 357 2.5k
17 168.8 14.6d 48.1 38b 210.7 14.31 145.6 7,7d 80.9 7,8 31.4 3,6b
24 173.4 20,OC 75.7 9,55 170.9 22.2b 176,0 l0.7d 83.9 3,4b 25.3 3,45
48 159.4 21.9k 82.0 4 l3l 216.8 l9.4 255.4 15,7d — —
a Values represent the mean SEM.
When compared to control (0 hour), P < 0.05.
When compared to control (0 hour), P < 0.01.
When compared to control (0 hour), P < 0.00!.
was significantly higher than that of nondehydrated pothesis, however, have been unsuccessful. The
or dehydrated animals at time zero and at 1 hour administration of antibodies directed against renin
after glycerol injection (Fig. 3). There was no dif- and All [21, 29] or the use of inhibitors of the action
ference between each series at 6, 17, and 48 hours or synthesis of All [30—32] fail to ameliorate the Se-
after glycerol injection, verity of experimental acute renal failure. Sirnilarly,
All content of kidneys at time zero and at 17 the administration of a subpressor dose of All dur-
hours after glycerol injection was not significantly ing the early phase of acute renal failure does not
different in all three groups. Kidneys from dehy- alter the degree of acute renal failure [33J. These
drated animals had increased All contents corn- data, however, do not exclude the possibility of a
pared to the nondehydrated group at 1, 24, and 48 role for the intrarenal renin-angiotensin system in
hours. There was a significant depression of All in the generation and/or maintenance of acute renal
the dehydrated group at 6 hours and a significant failure.
rise, as compared to the nondehydrated and saline- Involvement of the intrarenal renin-angiotensin
loaded groups, at 24 hours. system in the pathogenesis of acute renal failure
would require the local generation of high concen-
Discussion trations of All in the vicinity of the juxtaglomerular
It has been repeatedly proposed that the renin- cells. Angiotensin would then gain access to the af-
angiotensin system is involved in the pathogenesis ferent arteriole to elicit arteriolar constriction and
of acute renal failure [1—14]. In support of this hy- reduce renal blood flow and GFR.
pothesis is the observation that chronic salt-load- Since renin and All reactive material have been
ing, a maneuver known to depress renin activity, shown to be present in significant concentrations in
protects against experimentally induced acute renal renal lymph [261, it seems feasible that marked in-
failure [9—12, 21]. Other attempts to support this hy- creases in interstitial All during acute renal failure
Table 2. Intrarenal angiotensin I and 11 content in glycerol-induced acute renal failurea
Nondehydrated Dehydrated Saline-loaded(N = 12 rats/time period; total = 72) (N = 8 rats/time period; total = 48) (N = 8 rats/time period; total = 40)
Time Al All At All Al All
hr ag/kidney ag/kidney ng/kidney ag/kidney ag/kidney ng/kidney
0 1.66 0.30 1.28 0.33 1,47 0.06 1.29 0.04 5.19 1.22 1.20 0.15
I 2.17 0.40 0.69 0.06 1.72 0.11 1.26 0.12 4.12 0.64 0.97 0.10
6 5.80 l,23 1.55 0.16 3.97 030 0.91 0.05d 3.57 0,54 1.20 0.08
17 16.05 3.IOC 1.59 0.15 30.48 773e 2.63 0,47C 12.8! 3.69 2.10 0.47
24 7.49 1.15C 0.93 0.12 44.06 lS.60b 3.00 0.75 6.90 1.97 0.97 0.18
48 6.69 0.69C 1.2! 0.15 12.4! 3.25k 2.49 0.4l — —
a Values represent the mean SCM.
b When compared to control (0 hour), P < 0.05.
C When compared to control (0 hour), P < 0.01.
When compared to control (0 hour), P < 0.001.
could also mediate a reduction in glomerular capil-
lary blood flow and permeability as the result of a
direct effect on the glomerulus. Therefore, in the
present study this important issue was reexamined
by serial determinations of intrarenal renin and Al
and All profiles throughout the course of acute re-
nal failure.
First, the intrarenal renin content under three ex-
perimental conditions was assessed. After 3 weeks
of salt-loading, intrarenal renin content was signifi-
cantly lower than that in nondehydrated and dehy-
drated animals. This observation and the fact that
salt-loading protects from [9—12, 211, whereas dehy-
dration predisposes to, severe renal failure [13] are
in agreement with previous investigations.
Although intrarenal renin in salt-loaded animals
rose at 24 hours after glycerol injection, at no time
throughout the course of renal failure did it reach
the levels observed in dehydrated or nondehydrated
animals. This pattern concurs with that reported by
Rauh et al [8] and seems to support the suggestion
that intrarenal renin has a significant role in acute
renal failure. To draw this conclusion, however,
one must demonstrate that an elevation of intra-
renal renin content temporarily coincides with a sig-
nificant decline in renal function. Since in the study
by Rauh et al [8] and in the present experiments the
peak in intrarenal renin followed the decline in renal
function (as assessed by the early rise in blood urea
nitrogen), it is difficult to ascribe a causal role to
intrarenal renin in the genesis of acute renal failure.
The failure to demonstrate an early increase in
renin content may reside in the inability to distin-
guish between its inactive and active moeity [34].
Another explanation for this observation could be
that renin synthesized under the conditions of acute
renal failure might possess altered kinetic proper-
ties. In addition, an increased rate of release of re-
nm into the systemic circulation could result in
unaltered levels of intrarenal renin. An increased
rate of renin release, however, has not been detect-
ed by measurements of peripheral renin activity
[3, 30], which does not increase early in acute renal
failure. If any of these mechanisms occurred, we
would not be able to interpret our measurements of
intrarenal renin. Since the product (Al) of the reac-
tion of renin and its substrate was measured, the dif-
ficulty encountered by the exclusive determination
of renin is eliminated. It is interesting to note, how-
ever, that intrarenal renin during acute renal failure
generally parallels the level of intrarenal Al.
Al and All were unchanged in all groups early in
acute renal failure, a time when renal function was
depressed. The levels of Al and All in salt-loaded
animals remained unaltered. The increase in the
levels of Al occurred only after renal failure was
established. Although the levels of All were signifi-
cantly increased only in the late phase of severe
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Fig. 3. Comparison of intrarenal angiotensin I and II contents of nondehydrated, dehy-
drated, and saline-loaded rats before and at different times after glycerol injection.
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acute renal failure, the magnitude of this elevation
was small in relation to the increase in Al.
The disparity in the ratio of Alto All in the other
groups during acute renal failure is also apparent.
This observation has at least two possible ex-
planations. The kinetic properties of intrarenal con-
verting enzyme or the availability of this enzyme to
its substrate may be altered in acute renal failure,
thereby limiting the synthesis of All. Second, the
unimpressive change in All may result from accel-
erated breakdown of All. Although our data do not
permit confirmation of this possibility, reports show
that renal angiotensinases are depressed in another
experimental model of acute renal failure [35J. The
likelihood of the conversion of All to des-Asp1-an-
giotensin II (AlIT) by an aminopeptidase can be ex-
cluded since All! was recovered from kidney ho-
mogenates and the antibody used in the present
study crossreacts to a high degree with All!. There-
fore, this peptide would have been measured in the
renal extracts.
The physiologic role of intrarenal AT is not defi-
nite; some investigators have demonstrated that A!
without conversion to All modifies the distribution
of intrarenal blood flow [36, 37J. The patho-
physiologic consequences of an elevated intrarenal
A! concentration in acute renal failure is not
known.
In summary, intrarenal renin, A!, and A!! are
unaltered early in the course of acute renal failure.
Since the loss of renal function occurs at a time
when these agents are not elevated, we conclude
that it is unlikely that angiotensins participate in the
genesis of glycerol-induced acute renal failure. We
cannot exclude their participation in the late or
maintenance phase of the syndrome.
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